Silence Therapeutics Plc - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Silence Therapeutics Plc. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Silence Therapeutics Plc. The Group's principal activity is researching and developing pharmaceutical products. It focuses on Ribonucleic Acid Interference technology, as it can selectively silence genes linked to the onset of disease, thus leading to the creation of a new class of therapeutic products. The Group is developing two products relating to Age-Related Macular Degeneration and Acute Kidney Injury. The Group operates in the United Kingdom.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report